SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-148062
Filing Date
2017-04-28
Accepted
2017-04-28 16:01:57
Documents
13
Period of Report
2017-06-13
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A d358174ddef14a.htm DEF 14A 293964
2 GRAPHIC g358174g11e19.jpg GRAPHIC 5421
3 GRAPHIC g358174g12v18.jpg GRAPHIC 980
4 GRAPHIC g358174g21b38.jpg GRAPHIC 30775
5 GRAPHIC g358174snap10.jpg GRAPHIC 2393
6 GRAPHIC g358174snap12.jpg GRAPHIC 911
7 GRAPHIC g358174snap13.jpg GRAPHIC 1139
8 GRAPHIC g358174snap17.jpg GRAPHIC 4933
9 GRAPHIC g358174snap20.jpg GRAPHIC 789
10 GRAPHIC g358174snap21.jpg GRAPHIC 721
11 GRAPHIC g358174snap7.gif GRAPHIC 94
12 GRAPHIC g358174snap8.gif GRAPHIC 97
13 GRAPHIC g358174snap9.jpg GRAPHIC 723
  Complete submission text file 0001193125-17-148062.txt   364370
Mailing Address 4545 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4545 TOWNE CENTRE COURT SAN DIEGO CA 92121 (858) 255-5959
Ignyta, Inc. (Filer) CIK: 0001557421 (see all company filings)

IRS No.: 453174872 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36344 | Film No.: 17795317
SIC: 2834 Pharmaceutical Preparations